| 678038 |
FRONTIERS IN ONCOLOGY |
A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma |
2021-04-16 |
10.3389/fonc.2021.643159 |
Zhang Yu, Yang Xin, Zhu Xiao-Lin, Wang Zhuang-Zhuang, Bai Hao, Zhang Jun-Jie, Hao Chun-Yan, Duan Hu-Bin |
| 678037 |
FRONTIERS IN ONCOLOGY |
Prognostic Nomogram for Postoperative Patients With Gastroesophageal Junction Cancer of No Distant Metastasis |
2021-04-16 |
10.3389/fonc.2021.643261 |
Guo Qiang, Peng YuanYuan, Yang Heng, Guo JiaLong |
| 678036 |
FRONTIERS IN ONCOLOGY |
Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma |
2021-04-16 |
10.3389/fonc.2021.575425 |
Zhang Shiqiang, Zheng Wenzhong, Jiang Donggen, Xiong Haiyun, Liao Guolong, Yang Xiangwei, Ma He, Li Jun, Qiu Miaojuan, Li Binbin, Sun Chunhui, Zhao Jing, Wang Liling, Pang Jun |
| 678035 |
FRONTIERS IN ONCOLOGY |
Rectum Protection by Rectal Gel Injection in Cervical Cancer Brachytherapy: A Dosimetric Study via Deformable Surface Dose Accumulation and Machine-Learning-Based Discriminative Modeling |
2021-04-16 |
10.3389/fonc.2021.657208 |
Wang Xuetao, Zhang Bailin, He Qiang, Kong Yilin, Dai Zhenhui, Meng Haoyu, Huang Fangjun, Zhang Shengfeng, Zhu Yuanhu, Tan Xiang, Zhen Xin |
| 678034 |
FRONTIERS IN ONCOLOGY |
Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors |
2021-04-16 |
10.3389/fonc.2021.644134 |
Guo Kaibo, Feng Yuqian, Zheng Xueer, Sun Leitao, Wasan Harpreet S., Ruan Shanming, Shen Minhe |
| 678033 |
FRONTIERS IN ONCOLOGY |
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer |
2021-04-16 |
10.3389/fonc.2021.634316 |
Freitas Cláudia, Sousa Catarina, Machado Francisco, Serino Mariana, Santos Vanessa, Cruz-Martins Natália, Teixeira Armando, Cunha António, Pereira Tania, Oliveira Hélder P., Costa José Luís, Hespanhol Venceslau |
| 678032 |
FRONTIERS IN ONCOLOGY |
Unique Combination of Diamond–Blackfan Anemia and Lynch Syndrome in Adult Female: A Case Report |
2021-04-16 |
10.3389/fonc.2021.652696 |
Tsukanov Aleksey S., Pikunov Dmitriy Y., Shubin Vitaly P., Barinov Aleksey A., Kashnikov Vladimir N., Shelygin Yuri A., Kaprin Andrey D., Filonenko Elena V., Sidorov Dmitriy V., Maschan Aleksey A., Novichkova Galina A., Yasko Liudmila A., Raykina Elena V., Rumyantsev Aleksandr G. |
| 678031 |
FRONTIERS IN ONCOLOGY |
LCT-3d Induces Oxidative Stress-Mediated Apoptosis by Upregulating Death Receptor 5 in Gastric Cancer Cells |
2021-04-16 |
10.3389/fonc.2021.658608 |
Wang Menglin, Wu Xinxin, Yu Lu, Hu Zi-yun, Li Xiaobo, Meng Xia, Lv Chun-tao, Kim Gi-Young, Choi Yung Hyun, Wang Zhengya, Xu Hai-Wei, Jin Cheng-Yun |
| 678030 |
FRONTIERS IN ONCOLOGY |
Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway |
2021-04-16 |
10.3389/fonc.2021.659676 |
Hu Jiejun, Cai Dong, Zhao Zhibo, Zhong Guo-Chao, Gong Jianping |
| 678029 |
FRONTIERS IN ONCOLOGY |
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis |
2021-04-16 |
10.3389/fonc.2021.562315 |
Chen Shixue, Zhang Zhibo, Zheng Xuan, Tao Haitao, Zhang Sujie, Ma Junxun, Liu Zhefeng, Wang Jinliang, Qian Yuanyu, Cui Pengfei, Huang Di, Huang Ziwei, Wu Zhaozhen, Hu Yi |
